Robert Y-S Cheng Selected Research

Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)

9/2012	Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
9/2012	S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.
11/2011	Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Y-S Cheng Research Topics

Disease

5	Neoplasms (Cancer) 09/2012 - 05/2004
4	Breast Neoplasms (Breast Cancer) 09/2012 - 11/2011
2	Neoplasm Metastasis (Metastasis) 09/2012 - 05/2012
1	Carcinogenesis 05/2004

Drug/Important Bio-Agent (IBA)

4	Estrogen ReceptorsIBA 09/2012 - 11/2011
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2012 - 11/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012 - 11/2011
1	ElementsIBA 09/2012
1	Cadherins (E-Cadherin)IBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2012
1	Crystallins (Crystallin)IBA 09/2012
1	RNA (Ribonucleic Acid)IBA 09/2012
1	Proto-Oncogene Protein c-ets-1IBA 09/2012
1	CateninsIBA 09/2012
1	Estrogens (Estrogen)FDA Link 05/2012
1	Transcription Factors (Transcription Factor)IBA 05/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2011
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2011
1	Ribosomal RNAIBA 05/2004
1	CarcinogensIBA 05/2004

Therapy/Procedure

1	Therapeutics 05/2012
1	Chemoprevention 05/2012